Study identifier:NIS-NES-SER-2006/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Adherence in adolescents and children treated on quetiapine
Psychosis
-
No
-
All
30
Observational
7 Years - 17 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
1 Children and adolescents with psychosis in outpatients setting on treatment with quetiapine started from january 2003 to june 2006 | - |